Peter Mencel

602 total citations
10 papers, 359 citations indexed

About

Peter Mencel is a scholar working on Surgery, Molecular Biology and Rheumatology. According to data from OpenAlex, Peter Mencel has authored 10 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Peter Mencel's work include Testicular diseases and treatments (4 papers), Urologic and reproductive health conditions (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Peter Mencel is often cited by papers focused on Testicular diseases and treatments (4 papers), Urologic and reproductive health conditions (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Peter Mencel collaborates with scholars based in United States. Peter Mencel's co-authors include Robert J. Motzer, Dean F. Bajorin, George J. Bosl, Madhu Mazumdar, Vaia Vlamis, Harry W. Herr, Joel Sheinfeld, Robert T. Heelan, H.W. Herr and R T Heelan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Peter Mencel

10 papers receiving 342 citations

Peers

Peter Mencel

SURGE

RHEUM

PRM

NEURO

MB

G. Jay United Kingdom

H. Yosef United Kingdom

R. Bastús Spain

R. Bußar-Maatz Germany

AE Stenwig Norway

Steven A. Clark United States

Craig Nichols United States

Josep Ramón Germà-Lluch Spain

Dirk Th. Sleyfer Netherlands

C. Clemm Germany

G. Jay United Kingdom

Peter Mencel

305 ×1.0

SURGE

81 ×0.6

RHEUM

101 ×0.7

PRM

96 ×0.8

NEURO

74 ×1.2

MB

Citations per year, relative to Peter Mencel Peter Mencel (= 1×) peers G. Jay

Countries citing papers authored by Peter Mencel

Since Specialization

Citations

This map shows the geographic impact of Peter Mencel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mencel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mencel more than expected).

Fields of papers citing papers by Peter Mencel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mencel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mencel. The network helps show where Peter Mencel may publish in the future.

Co-authorship network of co-authors of Peter Mencel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mencel. A scholar is included among the top collaborators of Peter Mencel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mencel. Peter Mencel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gupta, Varsha, Mohammed Shariff, Ravneet Bajwa, et al.. (2019). Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse. World Journal of Oncology. 10(3). 153–156. 2 indexed citations

2.

Shifrin, Alexander L., et al.. (2013). Neuroendocrine Thymic Carcinoma Metastatic to the Parathyroid Gland that was Reimplanted into the Forearm in Patient with Multiple Endocrine Neoplasia Type 1 Syndrome: A Challenging Management Dilemma. Endocrine Practice. 19(6). e163–e167. 3 indexed citations

3.

Mencel, Peter, et al.. (2010). A Case of FVII Inhibitor.. Blood. 116(21). 3655–3655. 1 indexed citations

4.

Reiss, Krzysztof, et al.. (2008). PPARα agonist fenofibrate inhibits IGF-I - mediated growth and DNA repair responses and sensitizes human glioblastoma cells to cisplatin. Journal of Clinical Oncology. 26(15_suppl). 13020–13020. 1 indexed citations

5.

Herr, Harry W., Joel Sheinfeld, Robert T. Heelan, et al.. (1997). Surgery for a Post-Chemotherapy Residual Mass in Seminoma. The Journal of Urology. 157(3). 860–862. 94 indexed citations

6.

Herr, Harry W., Joel Sheinfeld, Robert T. Heelan, et al.. (1997). Surgery for a Post-Chemotherapy Residual Mass in Seminoma. The Journal of Urology. 860–862. 3 indexed citations

7.

Heelan, R T, Madhu Mazumdar, H.W. Herr, et al.. (1996). Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.. Journal of Clinical Oncology. 14(2). 454–460. 111 indexed citations

8.

Mencel, Peter, Lisa M. DeAngelis, & Robert J. Motzer. (1994). Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma. Cancer. 73(7). 1892–1894. 25 indexed citations

9.

Law, Teresa Murray, Peter Mencel, & Robert J. Motzer. (1994). Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma. Investigational New Drugs. 12(4). 323–325. 18 indexed citations

10.

Mencel, Peter, Robert J. Motzer, Madhu Mazumdar, et al.. (1994). Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.. Journal of Clinical Oncology. 12(1). 120–126. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact